Morning Briefing
Summaries of health policy coverage from major news organizations
FTC Wants To Ban 'Pay-To-Delay' Settlements Related To Generic Drugs
The Federal Trade Commission is hoping to ban the practice in which drug companies pay their generic counterparts to delay the release of generic alternatives to popular pharmaceuticals.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
